Loading
Velocity Clinical Research, Inc.
Velocity Clinical Research, Inc. is a leading organization of fully integrated clinical research sites, based in Durham, North Carolina. Founded in 2017, the company operates over 70 to 100 sites across the U.S. and Europe, supported by more than 200 investigators. Velocity has been involved in over 15,000 studies, focusing on delivering high-quality data and exceptional patient care. As a Site Management Organization (SMO), Velocity offers unified research site solutions, including patient recruitment, study management, and centralized trial operations. Its integrated model enhances enrollment speed and site productivity. In January 2024, the company launched the VISION technology platform, aimed at improving patient access and participation in clinical trials. Velocity serves pharmaceutical and biotechnology companies, as well as Contract Research Organizations (CROs), with a focus on various therapeutic areas such as allergy, Alzheimer’s disease, cardiovascular disorders, and more. The company is committed to advancing clinical research through innovative technology and operational excellence.
Funding
Every round, secondary, debt facility or acquisition involving Velocity Clinical Research, Inc. that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$87M